Humanos raises $3.2M seed
Humanos raises $3.2M seed
Humanos raised $3.2M in seed funding led by Anthemis to build live risk scores and risk passports for AI agents.
Investment archive
Humanos raises $3.2M seed
Humanos raised $3.2M in seed funding led by Anthemis to build live risk scores and risk passports for AI agents.
Complaion raises €13.5M
Complaion closed a €13.5M financing led by Eurazeo and Italian Founders Fund to expand its SME compliance automation platform.
Balwaan Krishi raises ₹100 crore Series B
Balwaan Krishi raised ₹100 crore in Series B funding led by First Bridge India Growth Fund.
Modulate raises $25M
Modulate announced $25M in new funding led by Future Ventures, bringing total funding to $60M.
Quartermaster raises $100M Series B plus $40M debt
Quartermaster's $140M package combines about $100M of Series B equity led by Insight Partners with a $40M debt facility.
SiMa.ai raises $150M Series C at $1.45B valuation
SiMa.ai raised $150 million in primary Series C capital at a $1.45 billion valuation, taking total funding to $500 million.
Instinct raises $1B Series C at $10B valuation
Instinct raised a $1 billion Series C at a $10 billion valuation from Sequoia, Benchmark and Coatue.
Sofinnova MD Start IV €82M final close
Sofinnova Partners closed its oversubscribed MD Start IV fund at €82M to create six to eight medtech companies across Europe and the US.
IITM–Unicorn Frontier Fund I ₹450 crore first close
IITM–Unicorn Frontier Fund I reached a ₹450 crore first close toward a ₹1,000 crore target, including a ₹400 crore greenshoe, for early-stage Indian deep-tech companies.
Nscale $3.36B pre-IPO convertible-note financing
Nscale announced $3.36B of pre-IPO convertible loan notes, comprising $2.36B at closing and a $1B Nvidia commitment expected in mid-November.
BigHat Biosciences closes $75M Series C co-led by DFJ Growth and Premji Invest
AI protein engineering and clinical-stage therapeutic development; new round brings company-disclosed lifetime funding to $223M.
British Business Bank commits ~€87.2M to Advent Life Sciences Growth Fund
Confirmed institutional LP commitment, not a completed GP fund close. The separately stated €233M–€349M fundraising target is not actual raised capital.